Current Posters and Presentations
Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations include:
Association for Molecular Pathology (AMP)
Phoenix, AZ, November 14–16, 2013
Mitchell SM. RNA extraction from whole blood and bone marrow using simply RNA on the Maxwell 16 instrument.
Schumacher JA, Szankasi P, Kelley TW—Poster
Schumacher JA, Szankasi P, Kelley TW. A comparison of PCR primer sets for enrichment of TCRG rearrangements for next-generation sequencing of the T-cell gamma repertoire.
Wallander ML, Redpath S, Banks PM, Layfield LJ. Comparison of dual-ISH (DISH) and fluorescence in-situ hybridization (FISH) methodologies for the determination of HER2 status in breast carcinoma.
Szankasi P, Kelley TW—Poster
Szankasi P, Anderson D, Kelley TW. Comparison of quantitative BCR-ABL1 PCR testing results on paired peripheral blood/bone marrow aspirate specimens.
Coonrod EM, Durtschi J, Hill HR, Voelkerding KV, Kumanovics A—Poster
Coonrod EM, Durtschi J, Hill HR, Voelkerding KV, Kumanovics A. Performance of haloplex custom capture for clinical testing of primary immunodeficiencies by next-generation sequencing.
Schlaberg R. Sequencing for microorganism identification and characterization.
Sumner K, Swensen JJ, Lewis T, Wooderchak-Donahur W, Fong M, Brulotte B, Bayrak-Toydemir P, Pont-Kingdon G, Best DH—Poster
Sumner K, Swensen JJ, Lewis T, Wooderchak-Donahur W, Fong M, Brulotte B, Bayrak-Toydemir P, Pont-Kingdon G, Best DH. The clinical advantage of noncontiguous loop-out primers in the avoidance of problematic DNA sequences.
Elsberry D, Welker NC, Bronner MP—Poster
Elsberry D, Welker NC, Cho M-Y, Kim I-Y, Wilson AR, Bronner MP. Utility of thymidylate synthase genotyping for 5-fluorouracil chemotherapy in a large, colorectal cancer cohort study.
American Society for Histocompatibility and Immunogenetics (ASHI)
Chicago, IL, November 17–18, 2013
Profaizer T, Coonrod E, Delgado J, Kumanovics AA—Poster
Profaizer T, Coonrod E, Delgado J, Kumanovics AA. A comparison of physical and enzymatic fragmentation methods in library preparation for HLA sequencing on the Illumina MISEQ.
National Society of Genetic Counselors (NSGC)
Anaheim, CA, October 9–12, 2013
Calhoun MR, Carey JC, Hammond P, Lortz A, South ST, Rope A. Morphogenesis of the face in Wolf-Hirschhorn: three informative cases.
American College of Gastroenterology (ACG)
San Diego, CA, October 11–16, 2013
Delgado JC, Pavlov IY—Poster
Delgado JC, Pavlov IY, Kusukawa N, Skodack LA. Clinical laboratory validation of a functional assay for monitoring infliximab biological activity and neutralizing anti-infliximab antibodies.
North American Cystic Fibrosis Conference (NACFC)
Salt Lake City, UT, October 17–19, 2013
Lyon E , Groo B, Zhou L, Pham H, Nelson B, Wittwer C—Poster
Lyon E , Groo B, Zhou L, Pham H, Nelson B, Wittwer C. Full CFTR gene analysis using high-resolution melting as a second-tier test for newborn screening: a comprehensive approach.
American Society of Human Genetics (ASHG)
Boston, MA, October 22–26, 2013
Margraf RL, Coonrod EM, Durtschi J, Kumanovics A, Voelkerding KV—Poster
Margraf RL, Coonrod EM, Durtschi JD, Mallempati K, Kumanovics A, Newcomb TM, Optiz JM, Carey JC, Zhou H, Katz BE, Voelkerding KV, Swoboda KJ. A novel germline PIGA mutation in Ferro-Cerebro-Cutaneous syndrome: a neurodegenerative X-linked encephalopathy with epilepsy and systemic iron-overload.
Millson A, Lyon E—Poster
Millson A, Miller C, Lyon E. Classification and interpretation of CFTR, PRSS1, and SPINK1 sequence variants found in idiopathic and hereditary pancreatitis.
Sant DW, Margraf RL, Durtschi J, Voelkerding KV—Poster
Sant DW, Margraf RL, Durtschi J, Voelkerding KV. De novo germline mutations in MYL3 and DYNC1H1 genes discovered by exome sequencing in an infant with congenital joint contractures.
Fisch GS, South ST, Rutherford A, Falk R, Carey J. Deletion 2q37: cognitive-behavioral profiles, developmental trajectories, and IQ related to deletion size.
American College of Rheumatology (ACR)/Association of Rheumatology Health Professionals (ARHP)
San Diego CA, October 25–30, 2013
Tebo A, Willis R, Jaskowski T, Madger L, Petri M, Pierangeli S, Branch DW. Association of anti-B2glycoprotein i antibodies in a large cohort of lupus patients.
Tebo AE, Jaskowski TD—Poster
Tebo AE, Willis R, Jaskowski TD, Salmon JE, Petri M, Branch WD, Pierangeli SS. Isotype-dependent performance of b2glycoprotein I immunoassays in two diverse patient cohorts: implications for assay harmonization and standardization.
American College of Rheumatology (ACR)/
Association of Rheumatology Health Professionals (ARHP)
San Diego, CA, October 25–26, 2013
Jaskowski TD, Tebo AE—Poster
Nandiwada SL, Jaskowski TD, Mayes M, Satoh M, Tebo AE. Autoantibody diversity in a subset of scleroderma patients with positive ANA and negative for three major disease-specific markers.
Society of Forensic Toxicologists (SOFT)
Orlando, FL, October 28–November 1, 2013
Haglock CJ. Drugs and compounds in forensic toxicology.
Marin SJ. Fundamentals of accurate mass/targeted screening by LC-TOF-MS.
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Denver, CO, September 10–13, 2013
Tardif KD, Barker A—Poster
Tardif KD, Barker A. Identification of rapidly growing mycobacteria by MALDI-TOF mass spectrometry.
International Congress on Antiphospholipid Antibodies (APLA)
Rio de Janeiro, Brazil, September 18–21, 2013
Willis R, Tebo A, Lakos G, Mahler M, Norman GL, DW Branch, Salmon J, Guerra M, Pierangeli S, Branch DW. Anti-PS/PT (IGG) antibodies correlate with LAC and pregnancy complications in patients with antiphospholipid syndrome.
Tebo A, Jaskowski T—Oral Presentation
Tebo A, Willis R, Jaskowski T, Madger L, Petri M, Pierangeli S, Branch DW. Association of anti-B2glycoprotein I antibodies in a large cohort of lupus patients.
Tebo A, Jaskowski T—Poster
Tebo A, Willis R, Jaskowski T, Salmon J, Petri M, Pierangeli S, Branch DW. Qualitative comparisons of anti-b2glycoprotein I immunoassays in two distinct cohorts of patients.
International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT)
Salt Lake City, UT, September 22–26, 2013
Juenke JM, Johnson-Davis KL—Poster
Juenke JM, Brown PI, Johnson-Davis KL. Application of ultra-high liquid chromatography tandem mass spectrometry to the analysis of three atypical antipsychotics and one antidepressant: risperidone, 9-OH risperidone, aripiprazole ,dehydro-aripiprazole, ziprasidone, venlafaxine, and o-desmethyl-venlafaxine (ODES) in serum and plasma.
Haglock CJ, Strathmann FG—Presentation
Wise P, Haglock CJ, Strathmann FG. Assessment of arsenic toxicity using a combination of quantitative screening and chromatographic separation with inductively coupled plasma-mass spectrometry.
Meyer EJ, Schniedewind B, Boucher R, Johnson-Davis KL, Galinkin JL, Christians U. Cross-validation of Everolimus LC-MS/MS and Thermo Fisher QMS therapeutic drug monitoring assays—the Zortracker cross-validation and TDM support.
Marin SJ, McMillin GA—Poster
Marin SJ, Metcalf A, McMillin GA. Detection of in utero drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry (TOF).
Marin SJ, McMillin GA—Poster
Williams JA, Marin SJ, Chittamma A, Clark C, McMillin GA. Detection of in utero marijuana exposure by three methods using umbilical cord tissue.
Haglock CJ, Strathmann FG—Poster
Haglock CJ, Strathmann FG. Development and validation of a matrix-matched assay to measure iodine in serum by inductively coupled plasma-mass spectrometry.
Marin SJ, McMillin GA—Poster
Lawlor BG, Marin SJ, Chittamma A, Clark CJ, McMillin GA. Development of a qualitative urine drug panel by liquid chromatography time-of-flight mass spectrometry (LC-TOF-MS).
Garrison K, Johnson-Davis KL, Wong SH. Everolimus QMS assay by using Thermofisher Indiko, Beckman DXc, and AU680 analyzers and limited comparison to LC-MS/MS.
Haglock CJ, Strathmann FG—Poster
Parker R, Haglock CJ, Strathmann FG. Mercury amnesia: a simple and robust mercury whole blood assay using inductively coupled plasma mass spectrometry (ICP-MS) without memory effects.
Suh-Lailam BB, Juenke JM, Thompson CD, Johnson-Davis KL—Poster
Suh-Lailam BB, Juenke JM, Thompson CD, Wilson L, Johnson-Davis KL. Performance characteristics of three assays for the therapeutic drug monitoring of methotrexate.
Johnson-Davis KL. Urine drug testing and its role in pain management.
Campbell SC, McMillin G, Sherwin CMT, Spigarelli MG. Utilization of thiopurine methyltransferase pharmacogenomic testing.
11th Workshop on Bioinformatics and 6th Symposium of the Polish Bioinformatics Society
Wraclaw, Poland, September 27–29, 2013
Dittwald P, Valkenborg D, Jürgen Claesen J, Rockwood AL, Gambin A. A few comments on isotopic fine structure.